Full video transcriptClick to expand
Auto-generated transcript of @armonadibi's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00Should I start MK-677 at 16 years old?
- 0:04No, absolutely not. I even sell MK. We've been selling our MK for nine years now.
- 0:10It's called Ceromax, if people don't know.
- 0:13It's a top seller because it's dosed correctly.
- 0:16That's the problem with especially MK-677.
- 0:20Most all these companies, it's either under dosed, or there's other products, or there's other stuff in there that's not supposed to be in there.
- 0:27There's a lot of people that have taken MK-677 before, and they're like, well, I got this side effect, and this side effect, and this side effect.
- 0:35I'm like, those side effects do not come from MK-677, so wherever you got your MK-677 from, it's tainted with either a pro hormone or a SARM, and we make pure MK-677 that's dosed correctly at 25 milligrams per pill.
- 0:54It's recommended to start things at least way till you're 18, and that's just certain things like that.
- 1:02When you first start training and working out, you got to understand, you got to build a base that is natural.
- 1:08In the long run, you're going to make better gains.
- 1:12As soon as you start hitting the gym, everybody wants to start a cycle now.
- 1:16That's how it used to be, especially when I was growing up. We all built a base.
- 1:20I got up to 240 pounds without any gear at all, before I started taking gear.
- 1:28I was eating literally nine meals, sometimes 10 meals a day.
- 1:33Some days I would eat 30, 40 boiled eggs. I would literally stuff myself, and people just want to have abs get lean, look good all the time, but they don't want to put the working.
- 1:45You have to eat big if you want to grow big. Everybody's different. Everybody needs different amounts of food.
- 1:51Obviously that's what's coaching for. You guys need coaching.
- 1:55Link is in the bio. I've been doing it for over 20 years. There's so many bad coaches out there.
- 2:01I get people all the time that hire me, and they're doing this with their coach, this with their coach.
- 2:06Even coaches with some big names sometimes, and a lot of people are just not educated on everything about the body.
- 2:13I'm not talking about like, hey, here's a diet. Follow this. Anybody can get in shape if they're following them and have a diet.
- 2:20Your health matters. When to come off, when to take certain compounds.
- 2:25That's where I come in. I'll take my confidence with any client I get.
- 2:32Whoever they've come from, whatever coach, I can always make them better.
- 2:36Back to your question. No, you should not start in case 6, 7, 7, at 16.
- 2:42We sell the pills and the liquid. The liquid we made because a lot of women like the dose to the lower.
- 2:49That's the only difference because I get asked that all the time too. What's the difference between the pills and the liquid?
MK-677 muscle and GH claims: what the evidence actually shows
Quick answer
MK-677 (ibutamoren) is a non-peptide ghrelin receptor agonist that stimulates pulsatile GH secretion and downstream IGF-1 production. It has been studied in clinical trials for muscle wasting, GH deficiency, and age-related decline, but carries documented metabolic side effects including insulin resistance and elevated fasting glucose (Nass et al., 2008). Use in adolescents is not clinically evaluated and poses theoretical risks to still-developing endocrine axes and growth plate signaling.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 7 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For MK-677 muscle and GH claims: what the evidence actually shows, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Ipamorelin, the first selective growth hormone secretagogue
Background source for ipamorelin selectivity and GH-secretagogue mechanism.
PubMed
The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation
Preclinical context that should not be overstated as consumer clinical evidence.
PubMed
GLP-1 receptor agonists versus metformin in PCOS: a systematic review and meta-analysis
Used for PCOS pages comparing metabolic and weight-management approaches.
PubMed
The efficacy and safety of GLP-1 agonists in PCOS women living with obesity
Supports PCOS, obesity, and hormonal-regulation context.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
MK-677 muscle and GH claims: what the evidence actually shows is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "MK-677 muscle and GH claims: what the evidence actually shows" from Armon Adibi. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: MK-677 (ibutamoren) is a non-peptide ghrelin receptor agonist that stimulates pulsatile GH secretion and downstream IGF-1 production.
The reason this review is not generic is the source wording and the canonical claim label "peptides replying to amglabz wickepumps prepcoach ironogs supplements." In this clip, the useful excerpt is: "Should I start MK-677 at 16 years old?" That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Ipamorelin, the first selective growth hormone secretagogue (1998), The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation (2001), and Influence of chronic treatment with the growth hormone secretagogue Ipamorelin (2002), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
MK-677 (ibutamoren) is a non-peptide ghrelin receptor agonist that stimulates pulsatile GH secretion and downstream IGF-1 production.
FormBlends verdict
Peptide social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- MK-677 (ibutamoren) is a non-peptide ghrelin receptor agonist that stimulates pulsatile GH secretion and downstream IGF-1 production. It has been studied in clinical trials for muscle wasting, GH deficiency, and age-related decline, but carries documented metabolic side effects including insulin resistance and elevated fasting glucose (Nass et al., 2008). Use in adolescents is not clinically evaluated and poses theoretical risks to still-developing endocrine axes and growth plate signaling.
- MK-677 is not FDA-approved and is banned by WADA; purchasing it in the United States occupies a legal gray area with no regulatory quality oversight.
- A 2017 Drug Testing and Analysis study (Abbate et al.) found only 52% of sampled SARM and peptide products online contained what their labels claimed, supporting the adulteration concern raised in the video.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- MK-677 is not FDA-approved and is banned by WADA; purchasing it in the United States occupies a legal gray area with no regulatory quality oversight.
- A 2017 Drug Testing and Analysis study (Abbate et al.) found only 52% of sampled SARM and peptide products online contained what their labels claimed, supporting the adulteration concern raised in the video.
- A randomized controlled trial (Nass et al., 2008, Annals of Internal Medicine) found MK-677 increased insulin resistance and fasting glucose even at studied doses in older adults, independent of product purity.
- No clinical trials have evaluated MK-677 safety or efficacy in individuals under 18; use in adolescents with developing endocrine systems has no evidence base and meaningful theoretical risk.
- Long-term consequences of sustained IGF-1 elevation from GH secretagogues remain unresolved; cancer biology research has raised questions about chronic IGF-1 stimulation, though no causal human evidence currently exists for this class at therapeutic doses.
- The creator selling the same compound he advises against for minors is a direct conflict of interest that viewers should factor into how they weigh his product-specific claims.
- Water retention and increased appetite are pharmacological effects of MK-677 itself, not contamination markers; framing all adverse effects as a product quality issue understates the compound's real side effect profile.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @armonadibi actually say?
The creator gave a direct answer to a viewer asking about starting MK-677 at 16: "No, absolutely not." He also claimed that unusual side effects people blame on MK-677 are caused by tainted products spiked with prohormones or SARMs, not the compound itself. He promoted his own MK-677 product, Ceromax, dosed at 25 mg per pill, calling it "pure" and "dosed correctly." He also argued that young lifters should build a natural base before touching any compounds, citing his own path to 240 pounds without gear.
The core factual claims here are: MK-677 should not be used at 16, the supplement market for MK-677 is frequently adulterated, and the compound has a specific, predictable side effect profile when it is pure. He also offers coaching, and the self-promotional framing matters when evaluating objectivity.
Does the science back this up?
On the age question, yes. The concern is legitimate and grounded in biology, though the creator does not explain why. MK-677 (ibutamoren) is a ghrelin receptor agonist that stimulates growth hormone secretion. In adolescents, the hypothalamic-pituitary axis and growth plates are still developing, and exogenously spiking GH pulses during this window carries real theoretical risks to endocrine maturation.
On adulteration, he is on solid ground. A 2017 study by Abbate et al. in Drug Testing and Analysis analyzed 44 SARM and peptide products sold online and found that only 52% contained the labeled compound, and a significant portion contained undisclosed active ingredients including prohormones. A 2021 USADA-cited analysis reinforced that MK-677 products are among the more frequently mislabeled in the gray-market supplement space. His claim that unexpected side effects often point to contamination rather than pure MK-677 is consistent with this data.
The 25 mg dose claim is where things get more complicated. Clinical studies have used doses ranging from 10 to 50 mg, so 25 mg is within studied ranges, but presenting a specific dose as simply "correct" papers over meaningful individual variability.
What did they get wrong (or right)?
Credit where it is due: the age recommendation is right, the adulteration warning is real, and encouraging young lifters to train naturally before adding compounds is sensible advice backed by physiology. Adolescent resistance training produces robust adaptations without hormonal augmentation, and stacking compounds on top of a developmental system you do not fully understand yet is a bad trade.
What he got wrong, or at least oversimplified: his framing that pure MK-677 produces no unexpected side effects is too clean. Even in controlled clinical settings, MK-677 has been associated with increased fasting glucose, insulin resistance, and edema. A randomized controlled trial by Nass et al. (2008, Annals of Internal Medicine) specifically flagged increased insulin resistance as a concern. These are not contamination artifacts. They are pharmacological effects of the compound itself. Saying side effects "do not come from MK-677" without qualification is misleading.
His product promotion is also a conflict of interest that should be named. Recommending against a compound in 16-year-olds while selling that same compound in the same video is a tension worth noting.
What should you actually know?
MK-677 is not FDA-approved for any indication. It is classified as an investigational drug and is banned by WADA. Purchasing it exists in a legal gray zone depending on jurisdiction, and quality control in the gray market is genuinely poor. The adulteration data is real, and it matters.
For anyone considering MK-677 as an adult, the honest picture includes documented risks: elevated blood glucose, water retention, increased appetite beyond what some users want, and the unknown long-term effects of chronically elevated GH and IGF-1. The longevity implications of sustained IGF-1 elevation are debated, not resolved. Some cancer biology research raises questions about long-term IGF-1 stimulation, though no causal human evidence currently links therapeutic-range MK-677 use to cancer outcomes.
Age 16 is not the only line. Anyone with a personal or family history of glucose dysregulation, insulin resistance, or hormone-sensitive conditions should discuss this class of compound with an endocrinologist before considering it, regardless of age.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Armon Adibi · TikTok creator
81.4K views on this video
Replying to @¿ #amglabz #wickepumps #prepcoach #ironogs #supplementsthatwork #adibiarmy #coach #natty #enhanced #hypertrophy #gymtime #ifbb #npc #fitafter40 #ripped #openbodybuilding #wellness #amazon #gda #convey #openbodybuilding #gearedup #fitness #hypertrophy #dnpburn #mk677
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about mk-677?
MK-677 is not FDA-approved and is banned by WADA; purchasing it in the United States occupies a legal gray area with no regulatory quality oversight.
What does the video say about a 2017 drug testing?
A 2017 Drug Testing and Analysis study (Abbate et al.) found only 52% of sampled SARM and peptide products online contained what their labels claimed, supporting the adulteration concern raised in the video.
What does the video say about a randomized controlled trial (nass et al., 2008, annals of?
A randomized controlled trial (Nass et al., 2008, Annals of Internal Medicine) found MK-677 increased insulin resistance and fasting glucose even at studied doses in older adults, independent of product purity.
What does the video say about no clinical trials have evaluated mk-677 safety?
No clinical trials have evaluated MK-677 safety or efficacy in individuals under 18; use in adolescents with developing endocrine systems has no evidence base and meaningful theoretical risk.
What does the video say about long-term consequences of sustained igf-1 elevation from gh secretagogues remain?
Long-term consequences of sustained IGF-1 elevation from GH secretagogues remain unresolved; cancer biology research has raised questions about chronic IGF-1 stimulation, though no causal human evidence currently exists for this class at therapeutic doses.
What does the video say about the creator selling the same compound he advises against for?
The creator selling the same compound he advises against for minors is a direct conflict of interest that viewers should factor into how they weigh his product-specific claims.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Armon Adibi, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.